About OBaris
OBaris was founded in 2024 in Schlieren, Switzerland, within the medtech sector. A needle-free, self-applicable transdermal patch for injectables is developed by the company, designed for administration to the inner cheek. This technology serves as a painless alternative to traditional needle injections, with operations focused on patient medication management. Convenience and comfort are addressed through the patchs design, supporting users requiring regular treatments.
- Headquarter Schlieren, Switzerland
- Founders Nevena Paunovic, David Klein Cerrejon
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Johnson & Johnson
(Sep 04, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of OBaris
Detailed funding history for OBaris
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in OBaris
OBaris has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Johnson & Johnson.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare solutions are provided by Johnson & Johnson globally.
|
Locked | Locked | Locked |
Investor details for OBaris
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OBaris
Investment portfolio details for OBaris
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OBaris
Detailed financials for OBaris
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Obaris Comparisons
Peer comparison for OBaris
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OBaris
Detailed competitors of OBaris
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Obaris
Complete news archive for OBaris
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OBaris
OBaris was founded in 2024.
OBaris is headquartered in Schlieren, Switzerland. It is registered at Schlieren, Zurich, Switzerland.
David Klein Cerrejon is the current CEO of OBaris. They have also founded this company.
OBaris was founded in 2024 in Schlieren, Switzerland, within the medtech sector. A needle-free, self-applicable transdermal patch for injectables is developed by the company, designed for administration to the inner cheek. This technology serves as a painless alternative to traditional needle injections, with operations focused on patient medication management. Convenience and comfort are addressed through the patchs design, supporting users requiring regular treatments.
OBaris has 1 investor. Key investors include Johnson & Johnson.